Palmitoylethanolamide (PEA) is a member of the endocannabinoid fatty acid amides and exhibits potent anti-inflammatory and analgesic properties. Extensive clinical evidence supports the pleiotropic effects of PEA, where it appears to exert it's therapeutic effects via more than one mode of action, by modulating the endocannabinoid system in a safer and therapeutically efficacious manner. PEA is typically poorly water-soluble which affects oral absorption and bioavailability. Micronization helps reduce large PEA particles to the micron range (<10¼m), providing a larger total surface area and enables rapid dissolution and therapeutic efficacy corroborated by preclinical evidence. NFH Pain Relief SAP: Provides high quality micronized PEA for enhanced absorption, bioavailability, and efficacy. Helps relieve joint pain associated with osteoarthritis
Adults: Take 2-4 capsules daily or as directed by your healthcare practitioner. May take up to two weeks to notice the beneficial effects. Take daily for a minimum of two weeks for chronic pain relief.

Serving Size: One Capsule

Medicinal Ingredients
Palmitoylethanolamide (micronized) ... 300 mg Devil's claw (Harpagophytum procumbens) extract, 5% harpagosides ... 30 mg

Non-Medicinal Ingredients
Hypromellose, Magnesium stearate, Purified water, Silicon dioxide
Cautions and Warnings If symptoms persist or worsen, consult a health care practitioner. Consult a health care practitioner prior to use if you are pregnant or breastfeeding.